Actividades asistenciales
NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME
22/01/2026 -
The present invention relates to a novel compound for inhibiting nicotinamide phosphoribosyl transferase (NamPT), a composition including the same, and various uses thereof.
N-(5-SUBSTITUTED-[(1,3,4-THIADIAZOLYL) OR (1,3-THIAZOLYL)](SUBSTITUTED)CARBOXAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING THE AMIDE COMPOUNDS AND OF THEIR USE
22/01/2026 -
The present application discloses specific compounds of Formula (I) and their use in therapy, in particular, their use as Polymerase Theta (Polθ) inhibitors for the treatment of cancer. The...
TUMOR MICROENVIRONMENT-ACTIVATED CYTOKINE AND USE THEREOF
22/01/2026 -
A tumor microenvironment-activated cytokine interferon-alpha (IFNα) is prepared by mutating IFNα. After cysteine mutation of IFN-α, IFN-α is joined to a substrate and a mask body that can be...
TREATMENT AGENT FOR LUNG ADENOCARCINOMAS
22/01/2026 -
Provided are: a therapeutic agent for NK2 homeobox 1 (NKX2-1)-negative lung adenocarcinoma containing a Porcupine inhibitor as an active component; a NKX2-1-negative lung adenocarcinoma organoid;...
Inhibitors of MENIN-MLL Interaction
22/01/2026 -
The present invention is directed to the compounds 101 and 102—inhibitors of the interaction of menin and MLL. The inhibitors described herein can be useful in the treatment of diseases or...
COMPOUNDS AND METHODS FOR THE ENHANCED DEGRADATION OF TARGETED PROTEINS
22/01/2026 -
The present invention relates to bifunctional compounds, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which...
NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS
22/01/2026 -
A compound of general formula (I)or a pharmaceutically acceptable salt and/or solvate thereof, and the process for manufacturing the compound of general formula (I). Also, a pharmaceutical...
GENERATING MULTIPLE RESOLUTIONS OF A VIRTUAL REALITY ENVIRONMENT
22/01/2026 -
A method executed by a computing entity includes generating a virtual reality environment utilizing a group of object representations by identifying a set of common illustrative assets and...
SYSTEM AND METHOD FOR GENERATING IMAGES OF AN EYE
22/01/2026 -
A method of augmenting an eye image includes obtaining a first training image of a first type and applying a first function to obtain a first generated image of a second type. A second function is...
MACHINE-LEARNING-ENABLED IMPUTATION OF SPATIAL OMICS DATA BASED ON HISTOPATHOLOGY IMAGE DATA
22/01/2026 -
The present disclosure relates generally to machine learning techniques, and more specifically to machine learning techniques for generating synthetic spatial omics data based on histopathology...
TRAINING DATA FOR AIR DATA ESTIMATION IN AIRCRAFT
22/01/2026 -
A computer-implemented method of computing training data for training an air data estimator (106) to predict values of air data parameters (120) of an aircraft (100) comprises: selecting ground...
Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-4R) Antibodies
22/01/2026 -
The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human interleukin-4 receptor (hIL-4R). The formulations may contain, in addition...
Sleeve-Type Radioactive Source Delivery Assembly And Its Method of Use
22/01/2026 -
This present invention discloses a sleeve-type radioactive source delivery assembly and its method of use. The outer tube is sleeved over the outside of the inner tube, the front end of the inner...
OPTICAL WAVEGUIDE AND METHOD FOR MANUFACTURING THE SAME, AND AUGMENTED REALITY DISPLAY APPARATUS
22/01/2026 -
An optical waveguide, a method for manufacturing the same, and an augmented reality display device. The optical waveguide includes: a substrate; a grating being arranged on a surface of the...
COMPOSICIÓN FARMACÉUTICA DE VIRUS ADENOASOCIADO RECOMBINANTE
12/01/2026 -
<p>La presente invención se refiere al campo de los productos farmacéuticos, la terapia génica y la medicina, y más específicamente a composiciones farmacéuticas estables que...
INHIBIDORES DE PRMT5 Y USOS DE ESTOS
15/12/2025 -
La presente descripción se relaciona generalmente con compuestos que inhiben PRMT5. La descripción se relaciona además con el uso de los compuestos para la preparación de un medicamento para...
神経変性障害およびがんの処置に使用するためのアデノシン誘導体
16/01/2026 -
...
用于治疗炎性神经病症的组合物和方法
20/01/2026 -
...
新颖羧酰胺衍生物
20/01/2026 -
...
Actividades asistenciales
Agroalimentación
Automoción y nueva movilidad
Energía sostenible y eficiente
Materiales avanzados
Medio ambiente y sostenibilidad
Patrimonio natural y cultural
Procesos productivos e industria 4.0
Química y biotecnología
Salud y calidad de vida
Transformación digital



